Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Epigral Merger & Restructuring Worth ₹0.01 Cr

Epigral Limited incorporated a wholly-owned subsidiary, Epigral Advanced Materials Limited, for chemical manufacturing. The subsidiary has a paid-up capital of Rs. 1 lakh.

Key figures
Value₹0.01 Cr
Source

NSE filing, NSE: EPIGRAL. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Epigral Ltd: key numbers

Share price
₹874.50
Market cap
₹3,773 Cr
Revenue (annual)
₹2,527 Cr
Net profit (annual)
₹332.0 Cr
P/E (TTM)
13.9×Sector 34.1×
Promoter holding
68.83%+0.00% QoQ
FII holding
0.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Epigral Ltd

All →
16:46 IST BSE
Capacity Expansion

Epigral Capacity Expansion: ₹650 Cr Investment

Epigral Ltd will invest ₹650 Crore to add 1,25,000 TPA of Epoxy Resin & Formulations capacity at its Dahej facility, expected by H2 FY2028.

Value
₹650.0 Cr
Execution
By H2 FY2028

Other merger & restructuring announcements

All →